Locemia Solutions acquired by Eli Lilly and Company

Written by Kristie Cutillo | Oct 12, 2015 10:38:00 AM

Covington advised Locemia Solutions on the sale of worldwide rights to Locemia’s intranasal glucagon to Eli Lilly and Company (NYSE:LLY).

View full post